Abramson Cancer Center of the University of Pennsylvania is an NCI-Designated Comprehensive Cancer Center in Philadelphia, Pennsylvania, providing diagnosis and treatment for the full range of adult cancers. Pioneer of CAR T-cell therapy and proton therapy.
Awards and recognition
Birthplace of CAR T-Cell Therapy
Penn Medicine developed the first FDA-approved CAR T-cell therapy, transforming treatment for blood cancers.
NCCN Member Institution
One of roughly 30 elite cancer centers that make up the National Comprehensive Cancer Network — the panel that writes the treatment guidelines used by oncologists worldwide.
NCI-Designated Comprehensive Cancer Center
Holds the National Cancer Institute's highest designation, awarded only to centers that demonstrate depth in laboratory, clinical, and population-based research alongside outstanding patient care.